Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details Narrative)

v3.8.0.1
STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2017
Dec. 31, 2016
Oct. 19, 2016
Preferred stock, authorised 10,000,000 10,000,000 10,000,000  
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001 $ 0.0001  
Common stock, authorised 490,000,000 490,000,000 490,000,000  
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001 $ 0.0001  
Preferred stock, issued 0 0 0  
Preferred stock, outstanding 0 0 0  
Common stock, issued 64,628,622 64,628,622 61,628,622  
Common stock, outstanding 64,628,622 64,628,622 61,628,622  
Refundable deposit $ 3,000,000 $ 3,000,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants   484,448    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price   $ 0.58    
Options Exercisable 484,448 484,448    
Fair value of options   $ 602,224    
Stock-based compensation $ 335,757 602,224    
Intrinsic value of stock options outstanding 1,098,853 1,098,853    
Intrinsic value of stock options exercisable $ 1,098,853 $ 1,098,853    
Director [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants   40,000    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price   $ 1.49    
Chief Financial OfficerMember        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants   444,448    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price   $ 0.5    
Consulting Service Agreements [Member]        
Common stock, issued       1,552,500
Legal Service Agreements [Member]        
Common stock, issued       1,056,122